New Alzheimer’s Treatment Targets cPLA2 Enzyme
USC scientists identified compounds that target cPLA2, an enzyme linked to Alzheimer's inflammation, especially in APOE4 gene carriers. This offers a potential new therapeutic approach for the disease.
USC scientists identified compounds that target cPLA2, an enzyme linked to Alzheimer's inflammation, especially in APOE4 gene carriers. This offers a potential new therapeutic approach for the disease.